Design Therapeutics (DSGN)
NASDAQ:DSGN
US Market
Holding DSGN?
Track your performance easily

Design Therapeutics (DSGN) Technical Analysis

80 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Design Therapeutics’s (DSGN) Moving Averages Convergence Divergence (MACD) indicator is 0.02, suggesting Design Therapeutics is a Buy.
Design Therapeutics’s (DSGN) 20-Day exponential moving average is 5.21, while Design Therapeutics’s (DSGN) share price is $5, making it a Sell.
Design Therapeutics’s (DSGN) 50-Day exponential moving average is 4.96, while Design Therapeutics’s (DSGN) share price is $5, making it a Buy.

Design Therapeutics (DSGN) Pivot Points

Oct 05, 2024, 02:22 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.05
4.28
4.50
4.73
4.95
5.18
5.40
Fibonacci
4.28
4.45
4.56
4.73
4.90
5.01
5.18
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Design Therapeutics (DSGN) Moving Averages

Oct 05, 2024, 02:22 PM
Period
Simple
Exponential
MA5
5.04Sell
5.03Sell
MA10
5.21Sell
5.16Sell
MA20
5.40Sell
5.21Sell
MA50
4.98Buy
4.96Buy
MA100
4.46Buy
4.55Buy
MA200
3.75Buy
3.83Buy
Design Therapeutics’s (DSGN) 10-Day exponential moving average is 5.16, while Design Therapeutics’s (DSGN) share price is $5, making it a Sell.
Design Therapeutics’s (DSGN) 100-Day exponential moving average is 4.55, while Design Therapeutics’s (DSGN) share price is $5, making it a Buy.
Design Therapeutics’s (DSGN) stock price is $5 and Design Therapeutics’s (DSGN) 50-day simple moving average is 4.98, creating a Buy signal.
Design Therapeutics’s (DSGN) stock price is $5 and Design Therapeutics’s (DSGN) 100-day simple moving average is 4.46, creating a Buy signal.
Design Therapeutics’s (DSGN) stock price is $5 and Design Therapeutics’s (DSGN) 200-day simple moving average is 3.75, creating a Buy signal.

Design Therapeutics (DSGN) Technical Indicators

Oct 05, 2024, 02:22 PM
Name
Value
Implied Action
RSI (14)
46.65
Neutral
STOCH (9,6)
26.78
Neutral
STOCHRSI (14)
21.43
Neutral
MACD (12,26)
0.02
Buy
ADX (14)
31.21
Neutral
Williams %R
-69.75
Buy
CCI (14)
-123.59
Buy
ATR (14)
0.41
-
Ultimate Oscillator
48.12
Neutral
ROC
-9.91
Sell
Design Therapeutics’s (DSGN) Relative Strength Index (RSI) is 46.65, creating a Neutral signal.
Design Therapeutics’s (DSGN) Trend Strength Indicator (ADX) is 31.21, creating a Neutral signal.
Design Therapeutics’s (DSGN) Commodity Channel Index (CCI) is -123.59, creating a Buy signal.
Design Therapeutics’s (DSGN) Price Rate of Change (ROC) is -9.91, creating a Sell signal.

FAQ

Is DSGN a Buy, Hold, or Sell?
Based on DSGN’s technical indicators, DSGN is a Hold.
    What is DSGN’s RSI (14)?
    DSGN’s RSI (14) is 46.65, which suggests DSGN is a Neutral.
      What is DSGN’s MACD?
      DSGN’s MACD is 0.02, which suggests DSGN is a Buy.
        What is DSGN’s 5-day moving average?
        DSGN’s 5-day moving average is 5.04, which suggests DSGN is a Sell.
          What is DSGN’s 20-day moving average?
          DSGN 20-day moving average is 5.40, which suggests DSGN is a Sell.
            What is DSGN’s 50-day moving average?
            DSGN’s 50-day moving average is 4.98, which suggests DSGN is a Buy.
              What is DSGN’s 200-day moving average?
              DSGN’s 200-day moving average is 3.75, which suggests DSGN is a Buy.
                What is DSGN’s Williams % R (14)?
                DSGN’s Williams % R (14) is -69.75, which suggests DSGN is a Buy.
                  What is DSGN’s CCI (14)?
                  DSGN’s CCI (14) is -123.59, which suggests DSGN is a Buy.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis